Sage Journals: Discover world-class research

Abstract

The authors conducted a study of 510 patients at 18 Veterans Affairs medical centers to determine the benefit of coronary artery revascularization before elective major vascular surgery. hndications for operatior. were abdominal aortic aneurysm or arteria occlusive disease of the legs. Patients were randomzed to either revascularization before surgery or no revascular zation before surgery. Percutaneous procedures were performed in 593% and bypass surgery was performed n 41%b. At 30 days after ooeration, 120,,-of the revascularization group and 142 of the no-revascularization grouo had a myocardial in- farction and at 2.7 years after random.zation. 22% in the revascula izatior group and 23% in the no-revascularizat on grouu had d ed. The authors concluded that coronary artery revascularization before elective vascular surgery does not s gn fiantly al e-the ong-term outcome.

Keywords

coronary arter revascularization abdominal aortic aneurysm arterial occlusive disease

Get full access to this article

View all access options for this article.

References

1. Ilertzer NR , Beven EG , Young JR , et al. Coro nary arterv disease in peripheral vascular patients: a classification of 1000 coronary angiograms and results of surgical management. Ann Surg 199:223-233, 1984.

2. Eagle KA , Berger PB , Calkins H , et al. ACC/AHA guideline update for perioperative cardiovasculai evaluation for noncardiac surgery-exectitive summaiy: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). J Am Coll Cardiol 39:542-553, 2002.

3. Eagle KA , Coley CM , Newell JB , et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Int Med 110:859-866, 1989.

4. Goldman L , Caldera DL , Nussbaum SR , et al. Multifactorial index of cardiac risk in noncardiac stirgical procedures. N Engl J Med 297:845-850 1977.

5. Lee TH , Marcantonio ER , Mangion CM , et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100:1043-1049, 1999.

6. Rihal CS , Eagle KA , Mickel MC , et al. Coronary artery disease/myocardial infarction: Surgical therapy for coronaiy artery disease among patients with combined coronary artery and peripheral vascular disease. Ciiculation 91:46-53, 1995.

7. Poldermans, D , Boersma E , Bax JJ , et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341:1789-1794, 1999.

8. Stone GW , Ellis SG , Cox DA , et al. One-year clinical results with the slow-release, polymer-based paclitaxel-eluting TAXUS stent: the TAXUS IV trial. Circulation 109:1942-1947, 2004.

9. Holmes DR Jr , Leon MB , Moses JW , et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 109:634-640, 2004.

Coronary Artery Revascularization Before Elective Major Vascular Surgery

Abstract

Keywords

Get full access to this article

References